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a b s t r a c t
It is a consensus view that a strategy to increase heart resistance to ischaemia–reperfusion is awarranted.
Here, based on our previous study, we have hypothesized that a nicotinamide-rich diet could increase
myocardial resistance to ischaemia–reperfusion. Therefore, the purpose of this study was to determine
whether nicotinamide-rich diet would increase heart resistance to ischaemia–reperfusion and what is
the underlying mechanism. Experiments have been done on mice on control and nicotinamide-rich diet
(micewereaweekonnicotinamide-richdiet) aswell ason transgenicmiceoverexpressingSUR2A (SUR2A
mice), a regulatory subunit of cardioprotective ATP-sensitive K+ (KATP) channels and their littermate con-
trols (WT). The levels ofmRNA in heart tissueweremeasured by real-timeRT-PCR,whole heart and single
cell resistance to ischaemia–reperfusion and severe hypoxia was measured by TTC staining and laser
confocal microscopy, respectively. Nicotinamide-rich diet signiﬁcantly decreased the size of myocardial
infarction induced by ischaemia–reperfusion (from 42.5±4.6% of the area at risk zone in mice on control
diet to 26.8±1.8% in mice on nicotinamide-rich diet, n=6–12, P=0.031). The cardioprotective effect of
nicotinamide-rich diet was associated with 11.46±1.22 times (n=6) increased mRNA levels of SUR2A in
the heart. HMR1098, a selective inhibitor of the sarcolemmal KATP channels opening, abolished cardio-
protection afforded by nicotinamide-rich diet. Transgenic mice with a sole increase in SUR2A expression
had also increased cardiac resistance to ischaemia–reperfusion. We conclude that nicotinamide-rich diet
creaup-regulate SUR2A and in
. Introduction
Sarcolemmal KATP channels were originally discovered in
embrane patches excised from ventricular cardiomyocytes (sar-
olemmal KATP channels, [1]). These channels are heteromultimers
omposed of, at least, two distinct subunits. The pore-forming
nwardly rectifying K+ channel core, Kir6.2, is primarily responsible
or K+ permeance, whereas the regulatory subunit, also known as
he sulfonylurea receptor, or SUR2A, has been implicated in ligand-
ependent channel gating [2]. More recently, it has been suggested
hat the sarcolemmal KATP channel protein complex may be com-
osed of more proteins then just Kir6.2 and SUR2A, including
ir6.1 and enzymes regulating intracellular ATP levels and glycol-
sis [3–8]. Sarcolemmal KATP channels have been shown to play
crucial role in ischaemic preconditioning (a phenomenon when
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brief episodes of ischaemia/reperfusion protects the heart against
myocardial infarction [9]) and myocardial resistance to ischaemia
(reviewed in [10]).
Recent studies have shown that an increase in expression of
SUR2A increases the number of sarcolemmal KATP channels and
myocardial resistance to ischaemia/reperfusion [11]. We have
found out that female gender, young age or exposure to mild
hypoxia is associated with increased levels of SUR2A mRNA as
well as numbers of fully assembled KATP channels and heart resis-
tance to ischaemia/reperfusion [12–14]. When the mechanism of
hypoxia-induced increase in SUR2A expression was studied, it was
found that an increase in intracellular NAD triggers PI3 kinase sig-
nalling pathway leading to activation of SUR2 promoter via c-jun
transcription factor [12].
It has been reported that nicotinamide-rich diet increases the
intracellular levels of NAD [15]. If increase in NAD up-regulate
SUR2A and KATP channels in cardiac cells, then it is possible
Open access under CC BY license. that nicotinamide-richdietwould increasemyocardial SUR2A/KATP
channels and myocardial resistance to ischaemia. Therefore, we
have undertaken this study to examine whether nicotinamide-
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. Materials and methods
.1. Nicotinamide-rich diet
C57/BL6J male mice (4–6 weeks old) were fed ad libidum
ith RPM-1 (control diet) or RPM-1+0.5 g/kg nicotinamide
nicotinamide-rich diet; Special Diets Services). Each mouse was
ed for a week before used for experimentation. All experiments
onform to the Home Ofﬁce Regulations in UK. The experiments
ave been done under authority of Project Licences 60/3152 and
0/3925.
.2. SUR2A mice
Generation, breeding and genotyping of these mice have previ-
usly been described in detail [11]. All experiments conform to the
ome Ofﬁce Regulations in UK. The experiments have been done
nder authority of Project Licences 60/3152 and 60/3925.
.3. Real-time RT-PCR
Total RNA was extracted from cardiac ventricular tissue of mice
sing TRIZOL reagent (Invitrogen, Paisley, UK) according to the
anufacturer’s recommendations. ExtractedRNAwas furtherpuri-
ed with RNeasy Mini Kit (Qiagen, Crawley, UK) according to the
anufacturer’s instruction. The speciﬁc primers for mouse SUR2A,
ir6.2, Kir6.1, SUR1 and SUR2B were described in Ref. [11]. The
everse transcription (RT) reaction was carried out with ImProm-II
everse Transcriptase (Promega, Southampton, UK). A ﬁnal volume
f 20l of RT reaction containing 4l of 5× buffer, 3mM MgCl2,
0U of RNasin® Ribonuclease inhibitor, 1U of ImProm-II reverse
ranscriptase, 0.5mM each of dATP, dCTP, dGTP, and dTTP, 0.5g
f oligo(dT), and 1g of RNA was incubated at 42 ◦C for 1h and
hen inactivated at 70 ◦C for 15min. The resulting cDNA was used
s a template for real-time PCR. A SYBR Green I system was used
or the RT-PCR and the 25l reaction mixture contained: 12.5l
f iQTM SYBR® Green Supermix (2×), 7.5 nM each primers, 9l of
dH2O, and 2l of cDNA. In principle, the thermal cycling condi-
ions were as follows: an initial denaturation at 95 ◦C for 3min,
ollowed by 40 cycles of 10 s of denaturing at 95 ◦C, 15 s of anneal-
ng at 56 ◦C, and 30 s of extension at 72 ◦C. The real-time PCR was
erformed in the same wells of a 96-well plate in the iCycler
QTM Multicolor Real-Time Detection System (Bio-Rad, Hercules,
A). Data was collected following each cycle and displayed graphi-
ally (iCycler iQTM Real-time Detection System Software, Version
.0A, BioRad, Hercules, CA). Primers were tested for their abil-
ty to produce no signal in negative controls by dimer formation
nd then with regard to the efﬁciency of the PCR reaction. Efﬁ-
iency is evaluated by the slope of the regression curve obtained
ith several dilutions of the cDNA template. Melting curve anal-
sis tested the speciﬁcity of primers. Threshold cycle values, PCR
fﬁciency (examined by serially diluting the template cDNA and
erforming PCR under these conditions) and PCR speciﬁcity (by
onstructing themelting curve)were determined by the same soft-
are. Each mouse cDNA sample was measured at three different
uantities, and duplicated at each concentration, the correspond-
ng no-RT mRNA sample was included as a negative control (blank
16]). The calculation of relative mRNA expression was performed
sdescribed [17]. The relative expression ratio(R) of SUR2A is calcu-
ated using equation R = (EK)CPK(CD-NRD)/(ER)CPR(CD-NRD) (when
he effect of control and nicotinamide-rich diet were assessed)
r R = (EK)CPK(WT-TG)/(ER)CPR(WT-TG) (when wild type and SUR2A
ransgenic mice were assessed) where EK is the real-time PCR efﬁ-
iency of a SUR2A gene transcript, ER is the real-time PCR efﬁciency
f GAPDH (reference) gene, CPK is the crossing point deviation of
ontrol-nicotinamide-rich diet (CD-NRD) or wild type-transgeneResearch 61 (2010) 564–570 565
(WT-TG) of SUR2A gene transcript while CPR is the crossing point
deviation of control-nicotinamide-rich diet (CD-NRD) orwild type-
transgene (WT-TG) of GAPDH gene transcript.
2.4. Heart collection and ischaemia–reperfusion injury
The heart collection and ischaemia–reperfusion injury was per-
formed as described in details in our previous papers [18]. In brief,
mice were killed by cervical dislocation (according to UK Home
Ofﬁce procedures), and the hearts rapidly removed and placed in
ice-cold Tyrode’s solution at 4 ◦C. The aorta was then cannulated
and secured using 4–0 silk suture and the hearts were attached to
a custom-made Langendorff perfusion apparatus. Hearts were per-
fused at a constant ﬂow rate of 5ml/min at 37 ◦C with oxygenated
(95% O2, 5% CO2; the PO2 in perfusate was ∼600mmHg) Tyrode’s
solution (in mM: NaCl 136.5, KCl 5.4, CaCl2 1.8, MgCl2 0.53, glu-
cose (Glc) 5.5, HEPES-NaOH 5.5, pH 7.4) for a stabilization period
of 30min. The heart was then subjected to 30min of ischaemia
by placing it into degassed Tyrode’s (the solution was degassed
with argon for 60min and the PO2 in this solution was ∼20mmHg)
and switching off perfusion. A second 30min reperfusion with
oxygenated Tyrode’s followed the ischaemia. When HMR1098
was used, it was present in the Tyrode solution throughout
experimental protocol. After reperfusion, hearts were snap-frozen
in liquid nitrogen and stored at −80 ◦C. The frozen heart was
divided into approximately 5–6 transverse sections, which were
weighed before staining for 1h in 10% triphenyltetrazolium chlo-
ride (TTC) in phosphate buffer saline (PBS; both Sigma–Aldrich,
Dorset, UK) at 37 ◦C. The stain was ﬁxed in 4% paraformalde-
hyde (Sigma–Aldrich) for 30min, following which, the tissue was
photographed and the area of infarcted tissue measured using
Image Analysis software [18]. Infarct sizes were calculated as
(A1 ×W1) + (A2 ×W2) + (A3 ×W3) + (A4 ×W4) + (A5 ×W5), where A
is the area of infarct for the slice and W is the wt of the respective
section [18].
2.5. Isolation of single cardiomyocytes
Ventricular cardiomyocytes were dissociated from the mouse
using anestablishedenzymatic procedure [19]. In brief, heartswere
retrogradely perfused (at 37 ◦C) with medium 199, followed by
Ca2+-EGTA-buffered low-Ca2+ medium (pCa=7), and ﬁnally low-
Ca2+ medium containing pronase E (8mg per 100ml), proteinase
K (1.7mg per 100ml), bovine albumin (0.1 g per 100ml, fraction
V) and 200M CaCl2. Ventricles were cut into fragments in the
low-Ca2+ medium enriched with 200M CaCl2. Cells were isolated
by stirring the tissue (at 37 ◦C) in a solution containing pronase E
and proteinase K supplemented with collagenase (5mg per 10ml).
The ﬁrst aliquot was removed, ﬁltered through a nylon sieve, cen-
trifuged for 60 s (at 300–400 rpm), and washed. Remaining tissue
fragmentswere re-exposed to collagenase, and isolation continued
for 2–3 such cycles.
2.6. Experimental protocol of severe cellular hypoxia
Severe hypoxia of isolated cardiomyocytes has been performed
as described [20]. Thus, cardiomyocytes were placed into Tyrode’s
solution (in mM: NaCl 136.5, KCl 5.4, CaCl2 1.8, MgCl2 0.53, glu-
cose 5.5, HEPES-NaOH 5.5, pH 7.4), plated out on glass coverslips
and paced to beat by ﬁeld stimulation (parameters of the stim-
ulation: 5–20mV depending on cellular threshold, 5ms, 1Hz).
Beating cardiomyocytes were perfused with Tyrode solution at a
rate of 3ml/min and, under these conditions, the partial pressure
of O2 (PO2) in perfusate was 140mmHg. To induce severe hypoxia,
Tyrode solutionwas bubbledwith 100% argon (PO2 =20mmHgwas
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his level of hypoxia, solution was degassed for 60min). When
MR1098 was used, it was present in the Tyrode solution through-
ut experimental protocol. To clearly visualize cellswehave loaded
hem di-8-ANEPPS according to the manufacturer’s instruction
Invitrogen, Paisley, UK). Cells were imaged using laser confocal
icroscopy in line-scan mode (LSM-510, Zeiss, Göttingen, Ger-
any). Fluorescence was detected/imaged at 488nM excitation
avelength and emission was captured at >505nM. The moment
f cell death was deﬁned as the point when the cell has become
ounded (ratio of diameters <2 [21])..7. Statistical analysis
Data are presented as mean± SEM, with n representing the
umber of analysed mice or cells. Mean values were compared
ig. 1. Expression of SUR2A in hearts of mice on control and nicotinamide-rich diet. Re
) and GAPDH (B and D) cDNA from mice on control or nicotinamide-rich diet (as labe
ean± standard error of the mean (n=6 for each). *P<0.05.Research 61 (2010) 564–570
by the ANOVA followed by Student’s t-test, Mann–Whitney rank
sum test or by Chi-square test where appropriate using SigmaS-
tat program (Jandel Scientiﬁc, Chicago, IL). P<0.05 was considered
statistically signiﬁcant.
3. Results
3.1. SUR2A mRNA levels in mice on control and nicotinamide-rich
dietWe have analysed levels of SUR2A mRNA in mice that were
fed with control and nicotinamide-rich diet. Real-time RT-PCR
revealed that nicotinamide-richdiet signiﬁcantly increased the lev-
els of SUR2A mRNA in the heart as the threshold cycle for mice on
control and nicotinamide-rich diet was 32.1±0.3 and 27.7±0.9,
presentative progress curves for the real-time PCR ampliﬁcation of SUR2A (A and
lled on the ﬁgure) and a corresponding bar graphs (E and F). Each bar represents













































Pig. 2. Resistance of hearts to ischaemia–reperfusion from mice on control and nic
schaemia–reperfusion under depicted conditions. Infarcted areas are pale/grey whi
s a percentage of area at risk zone (n=6–12). *P<0.05.
espectively (n=6 for each, P<0.01, Fig. 1). On the other hand, no
igniﬁcant difference was found in GAPDH mRNA levels (Fig. 1;
hreshold cycle was 14.5±0.1 for mice on control and 14.4±0.2
n nicotinamide-rich diet, n=6 for each, P=0.85). It was calcu-
ated that mice on nicotinamide-rich diet had 11.46±1.22 times
ore SUR2A mRNA in the heart than mice on control diet (Fig. 1).
icotinamide-rich diet did not alter the expression of Kir6.2 and
ir6.1 (Kir6.1: threshold cycle for was 21.1±0.4 for mice on con-
rol and21.6±0.3 formice onnicotinamide-rich diet, P=0.23,n=6;
ir6.2: threshold cycle for was 22.7±1.7 for mice on control and
3.2±0.4 for mice on nicotinamide-rich diet, P=0.25, n=4–6).
.2. Nicotinamide-rich diet increases heart resistance to
schaemia–reperfusion
Ischaemia–reperfusion induced myocardial infarction in mice
n control diet that was 42.5±4.6% of the area at risk zone (n=12,
ig. 2). The size ofmyocardial infarctionwas signiﬁcantly smaller in
ice on nicotinamide-rich diet (26.8±1.8%, n=6, P=0.031, Fig. 2).
.3. A sole increase in SUR2A mimic the cardioprotective effect of
icotinamide-rich diet
In addition to up-regulating SUR2A expression, nicotinamide-
ich diet might have other effects. If nicotinamide-rich diet is
ardioprotective due to increased SUR2A expression, then a sole
ncrease in SUR2A would be sufﬁcient to mimic this effect of
icotinamide-rich diet. To determine whether increased expres-
ionof SUR2A is responsible for the increasedmyocardial resistance
o ischaemia–reperfusion, we have used SUR2A-overexpressing
ransgenic mice. It has been already reported that a sole increase in
UR2A increases myocardial resistance to ischaemia–reperfusion
n mice, but whether this is the case in male mice alone has not yet
een assessed. Therefore, we have assessed here myocardial resis-
ance exclusively of male mice overexpressing SUR2A. Real-time
T-PCRhas conﬁrmed that transgenic interventionhas signiﬁcantly
ncreased mRNA levels of SUR2A (cycling threshold was 24.3±0.2
n wild type and 21.6±0.7 in transgenics, n=6 for each, P<0.01,
ig. 3). No statistically signiﬁcant differencewas observed inmRNA
evels of other KATP channel-forming subunits (Fig. 3) as well as
APDH expression (cycling threshold was 18.9±0.5 in wild type
nd 19.1±0.3 in transgenics, n=6 for each, P=0.74). Transgenic
ice had 6.54±0.41 times more SUR2A mRNA then the wild type
n the heart.
In wild type, the size of myocardial infarction followed by
schaemia–reperfusion was 35.5±8.2% of the area at risk zone
n=9, Fig. 3). The size of myocardial infarction was signiﬁcantly
maller in transgenicmice (10.5±2.2% of the area at risk zone,n=5,
= 0.036, Fig. 3).mide-rich diet. (A) Typical photographs of myocardial slices from mice exposed to
le myocardium is dark/red. (B) Bar graphs depict myocardial infarct size expressed
To provide further evidence that improvement in myocardial
resistance to ischaemia/reperfusion is due to the effect that SUR2A
has on cardiomyocytes, we have tested the effect of severe hypoxia
in single cardiomyocytes from the two phenotypes. When exposed
to severe single cell hypoxia, 9 out of 14 cells from ﬁve wild type
males have died during ﬁrst 30min of severe hypoxia (Fig. 3). On
the other hand, all 28 tested cells from six male transgenic mice
have survived 30min-long severe hypoxia (Fig. 3).
3.4. HMR1098, a selective antagonist of sarcolemmal KATP
channels, abolishes cardioprotection afforded by nicotinamide
Apart on regulating expression of SUR2A, nicotinamide could
regulate the expression of other genes as well. It has been previ-
ously shown that inhibition of the activation of sarcolemmal KATP
channels inhibit cardioprotection afforded by increased sarcolem-
mal KATP channels [11]. Therefore, if the cardioprotective effect of
nicotinamide per os is mediated by up-regulation of SUR2A, then
HMR1098, a selective antagonist of sarcolemmal KATP channels
should block nicotinamide-mediated cardioprotection. Under con-
trol conditions 92.9±5.3% of cells from mice on nicotinamide per
oshave survived 30min-long severe hypoxia (1698 cells from three
mice were analysed). In contrast, only 53.7±10.5% of cardiac cells
from the same animals survived 30min of severe hypoxia (1863
cells from three mice were analysed) in the presence of HMR1098
(30M). The difference between cell survival in the absence and
presence of HMR1098was statistically signiﬁcant (Fig. 4, P<0.001).
Similar results were obtained at the whole heart level, where the
size of myocardial infarction in response to ischaemia–reperfusion
in the presence of HMR1098 (30M) was 51.7±3.1% (n=5), which
was signiﬁcantly different to this value obtained in the absence of
HMR1098 (26.8±1.8%,n=6,P<0.001, Fig. 4). The sizeofmyocardial
infarction in response to ischaemia–reperfusion was not different
between mice on control diet and mice on nicotinamide-rich diet
when the ischaemia–reperfusion was induced in the presence of
HMR1098 (30M, P=0.24; n=5–6, Fig. 4).
4. Discussion
Here, we have demonstrated that nicotinamide-rich diet pro-
tect the heart against ischaemia–reperfusion by increasing the
expression of SUR2A, a regulatory subunit of sarcolemmal KATP
channel.
It has been shown that conditions associated with increased
expression of SUR2A results in increase in myocardial resistance to
ischaemia–reperfusion, which seems to be due to increased num-
bers of sarcolemmal KATP channels [11–14]. It has been suggested
that up-regulation of SUR2A is sufﬁcient to increase numbers of
sarcolemmal KATP channels as this subunit seems to be the least








mig. 3. A sole increase in expression mimics the cardioprotective effect of nicotina
epresent cycling thresholds of the real-time RT-PCR progress curves of KATP chan
raphs depict myocardial infarct size expressed as a percentage of area at risk zon
ransgenic (SUR2A) mice exposed to hypoxia (magniﬁcation was 40×). Bar graph dxpressed KATP channel-forming protein making intracellular
UR2A level a rate-limiting step in assembling fully functional KATP
hannels [11]. The activation of these channels shortens action
embrane potential during ischaemia–reperfusion preventing-rich diet. (A) Real-time RT-PCR of KATP channel subunits in the heart. Bar graphs
rming subunits. Each bar represents mean± SEM (n=6 for each), *P<0.05. (B) Bar
5–9), *P<0.05. (C) Laser confocal images of cardiac cells from wild type (WT) and
percentage of cells that died/survived 30min-long hypoxia, n=14–28, *P<0.01.inﬂux of Ca2+ and Ca2+ overload, which is the main cause of cell
death under this condition. In addition to that, KATP channels also
seem to produce ATP during ischaemia and promote cell survival
bymaintaining physiological levels of subsarcolemmalATP [22,23].















































rig. 4. HMR1098, a selective antagonist of sarcolemmal KATP channels, abolishes ca
ells from mice on nicotinamide-rich diet in the absence (nicotinamide) or presence
=1698–1863, *P<0.01. (B) Bar graphs depicting myocardial infarct size in mice o
nicotinamide/HMR1098; n=5–6), *P<0.01.
he ATP producing property of KATP channels is probably due to the
resence of creatine kinase and glycolytic enzymes in sarcolemmal
ATP channel protein complex in vivo [5–8]. The dual mechanism
f cytoprotection by KATP channels [22,23] can probably explain
hy an increase in number of sarcolemmal KATP channels seems
o be a more efﬁcient in protecting the heart against ischaemia,
han just their activation [24].
It has been reported that an increase in intracellular NAD
timulate SUR2A expression by activating PI3-kinase signalling
athway that stimulates SUR2 promoter via c-jun transcription
actor [12]. Further experiments have demonstrated that increase
n intracellular NAD triggers signalling pathway that up-regulate
UR2A. Nicotinamide-rich diet is known to increase levels of NAD
n many tissues, although this has not been speciﬁcally reported
or the heart [15]. Here, we have shown that nicotinamide-rich
iet increases SUR2A mRNA in the heart, which supported our
ypothesis, based on results from previous studies [12,15], that
icotinamide-rich diet might up-regulate SUR2A by increasing
ntracellular NAD and activating SUR2 promoter.
Nicotinamide-rich diet has signiﬁcantly increased heart resis-
ance to ischaemia–reperfusion and this has never been shown
efore. In contrast to niacin, nicotinamide does not affect choles-
erol levels and has no use in treatment of dyslipidemia (reviewed
n [25]) and ex vivo design of our experiments has demon-
trated that nicotinamide-rich dieat increases cardiac resistance to
schaemia–reperfusion by direct action on the myocardium. As the
ardioprotection was associated with increase in SUR2A expres-
ion, it was feasible to conclude that increase in SUR2A levels is the
echanismunderlying cardioprotection affordedbynicotinamide-
ich diet.
However, nicotinamide-rich diet certainly has other effects in
ddition to SUR2A up-regulation (reviewed in [26]). It was there-
ore possible that increase in SUR2A was just an epiphenomenon
hat actually was not responsible for increased heart resistance to
schaemia–reperfusion. Therefore, we have used transgenic mice
ith solely increased expression of SUR2A devoid of any SUR2A-
ndependent effects that nicotinamide might have. Real-time
T-PCR has conﬁrmed that that transgenic mouse had increased
xpression of SUR2A while the expression of other KATP channel-
orming subunits has remained intact. It has been previously
uggested that SUR2A phenotype acquire resistance to myocar-
ial ischaemia–reperfusion, but this has been shown on mixed
ender population of mice [11]. Here, we have tested transgenic
ice and littermate controls that were gender and age-matched
ith mice on control and nicotinamide-rich diet. The obtained
esults have shown that a sole increase in SUR2A expression is suf-rotection afforded by nicotinamide-rich diet. (A) Bar graph depicting percentage of
M HMR 1098 (nicotinamide/HMR1098) that died following 30min-long hypoxia,
tinamide-rich diet in the absence (nicotinamide) or presence of 30M HMR 1098
ﬁcient to increase myocardial resistance to ischaemia–reperfusion.
Finally, the fact that HMR1098, a selective antagonist of the sar-
colemmal KATP channels opening, abolished nicotinamide-induced
cardioprotection on both single cell and whole heart levels pro-
vide a direct link between the increase in SUR2A, sarcolemmal
KATP channels and cardioprotection afforded by nicotinamide. It
has been previously shown that conditions with up-regulated
SUR2A is associated with increased numbers of sarcolemmal KATP
channels and increased cardiac resistance to metabolic stress.
In addition, SUR2A-mediated increase in heart resistance to
ischaemia–reperfusion was, without any exceptions, sensitive to
HMR1098 [11–14]. Thus, the effect of HMR1098 on nicotinamide-
induced cardioprotection is consistent with the notion that this
cardioprotection is mediated by up-regulation of SUR2A. The
efﬁciency of HMR1098 in blocking nicotinamide-mediated car-
dioprotection would imply that stimulation of SUR2A expression
is the main mechanism of cardioprotection afforded by nicoti-
namide.
Nicotinamide per os has been used so far to treat pellagra and
acne vulgaris and it is known as a very safe drug [27]. Here, for
the ﬁrst time we have shown that this compound could be used to
treat heart ischemia, which could be a perfect adjunct to current
therapeutic strategies against ischaemic heart diseases, based on
restitution of blood ﬂow to the heart and decrease of myocardial
metabolic demand (see also [24]).
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